Clinical Trials for Immorna Biotherapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Immorna Biotherapeutics

Clinical Trials (3)

NCT06781125
One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
PHASE1Not yet recruiting
72 participants
Started: Feb 10, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor0 locations
NCT06581575
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
PHASE2Active, not recruiting
467 participants
Started: Oct 16, 2024 · Completed: Aug 31, 2025
3 conditions2 sponsors8 locations
NCT06564194
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
PHASE1Active, not recruiting
75 participants
Started: Sep 25, 2024 · Completed: Jun 30, 2025
2 conditions2 sponsors3 locations